Novonesis Raises EUR 1.7 Billion in Bonds to Refinance Feed Enzyme Alliance Acquisition
Event summary
- Novonesis issued EUR 1.7 billion in senior unsecured notes to refinance its bridge facility from the Feed Enzyme Alliance acquisition.
- The bond issuance consists of three tranches with maturities ranging from 4 to 11 years and interest rates between 3.25% and 4.00%.
- The transaction was completed under Novonesis’ newly established EUR 4 billion Euro Medium Term Note (EMTN) Program.
- The Notes are rated in line with the company’s corporate credit rating of A with a stable outlook.
The big picture
Novonesis’ EUR 1.7 billion bond issuance underscores its commitment to consolidating control over the Feed Enzyme Alliance, a move that strengthens its position in the animal biosolutions value chain. The transaction reflects broader trends in biotechnology financing, where strategic acquisitions are increasingly funded through large-scale debt instruments. The company’s ability to secure favorable terms despite a competitive financing environment highlights its strong market standing.
What we're watching
- Debt Management
- How Novonesis will manage its increased debt load following this refinancing.
- Market Confidence
- Whether the strong investor interest reflects sustained confidence in Novonesis’ strategic direction.
- Execution Risk
- The pace at which Novonesis can integrate and capitalize on the Feed Enzyme Alliance acquisition.
Related topics